StockData
Turn Therapeutics Inc. logo

Turn Therapeutics Inc. (TTRX) shareholders

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$8.55+0.00 (0.00%)

Close on Nov 17, 2026Market cap $254.69MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
3.9%
1M of 30M shares
Institutional holders
29
11 new, 2 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $108.70K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Bradley Burnam15,716,26052.76%13G (passive)Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of TTRXValueChange% of portfolio
SteelPeak Wealth, LLC249,4560.84%$1.82MNew0.05%
Ieq Capital, LLC227,3960.76%$1.66MNew0.01%
DDFG, Inc107,8290.36%$787.15K+37,2950.16%
Vanguard Capital Management LLC74,3010.25%$542.40K+24,8510.00%
Wellington Shields & Co., LLC65,7320.22%$479.84K–0.11%
Millennium Management LLC60,5510.20%$442.02K−9,2060.00%
BlackRock, Inc.38,5910.13%$281.72KNew0.00%
Aaron Wealth Advisors LLC32,5640.11%$237.72KNew0.01%
Tamar Securities, LLC30,0000.10%$219.00K–0.02%
Royal Bank of Canada28,2500.09%$206.00KNew0.00%
Bridgewater Advisors Inc.27,3260.09%$241.56KNew0.01%
Citadel Advisors LLC25,8740.09%$188.88KNew0.00%
Brown Brothers Harriman & Co23,6880.08%$172.92K–0.00%
HighTower Advisors, LLC19,6840.07%$143.69K–0.00%
RVW Wealth, LLC18,0000.06%$131.40K–0.01%
Geode Capital Management, LLC17,1420.06%$125.14K–0.00%
Jefferies Financial Group Inc.16,3000.05%$118.99KNew0.00%
Miracle Mile Advisors, LLC16,0000.05%$116.80K–0.00%
McCarthy Asset Management, Inc.15,0180.05%$109.63KNew0.05%
Bank Of America Corp /De/14,1240.05%$103.11K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026291M3.9%11 / 42 / 21M0M
Q1 2026200M1.6%3 / 32 / 40M0M
Q4 2025220M1.6%22 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

6 funds held TTRX in Q2 2026, 77% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of TTRXValue% of fundAs of
Vanguard Total Stock Market Index Fund62,7490.21%$458.07K0.00%Jun 30, 2026
iShares Micro-Cap ETF36,2320.12%$264.49K0.02%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund17,1420.06%$89.14K0.00%May 31, 2026
Vanguard Balanced Index Fund9,8970.03%$72.25K0.00%Jun 30, 2026
1290 VT Micro Cap Portfolio2,3590.01%$17.22K0.01%Jun 30, 2026
Victory Extended Market Index Fund1,2440.00%$10.40K0.00%Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund1290.00%$9420.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Bradley Evan BurnamChief Executive Officer, Director, 10% owner15,416,26051.75%Jun 1, 2026
Neilesh Shailesh GhodadraChief Medical Officer, Director10,0000.03%Oct 10, 2025
Zuraiz ChaudharySee Remarks12,5000.04%Apr 3, 2026
Kent Edward KesterDirector10,0000.03%Jun 8, 2026
Andrew GengosDirector10,0000.03%Jun 8, 2026
Martin William DewhurstDirector21,8820.07%Jun 8, 2026
Arthur F. GoldenDirector360,6021.21%Jun 8, 2026
BEB Holdings, LLC10% owner15,716,26052.76%Jun 1, 2026
Abraham Chesed–1,447,2684.86%Oct 29, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Bradley Evan Burnam
Chief Executive Officer, Director, 10% owner
May 28, 2026Gift−300,000––15,116,260
Bradley Evan Burnam
Chief Executive Officer, Director, 10% owner
May 28, 2026Gift+300,000––300,000
Bradley Evan Burnam
Chief Executive Officer, Director, 10% owner
May 28, 2026Gift−300,000––15,416,260
Bradley Evan Burnam
Chief Executive Officer, Director, 10% owner
May 28, 2026Gift+300,000––300,000
Arthur F. Golden
Director
Apr 2, 2026Gift+300,000––360,602
BEB Holdings, LLC
10% owner
Apr 2, 2026Gift−300,000––15,716,260
Martin William Dewhurst
Director
Jan 7, 2026Award+21,882––21,882
Zuraiz Chaudhary
See Remarks
Dec 12, 2025Buy+2,500$3.50$8.75K12,500
Arthur F. Golden
Director
Nov 24, 2025Buy+9,868$3.44$33.95K60,602
Arthur F. Golden
Director
Nov 21, 2025Buy+20,532$2.87$58.93K50,734
Zuraiz Chaudhary
See Remarks
Nov 21, 2025Buy+1,000$3.29$3.29K10,000
Zuraiz Chaudhary
See Remarks
Nov 20, 2025Buy+1,450$2.61$3.78K9,000
Zuraiz Chaudhary
See Remarks
Nov 17, 2025Buy+2,500$3.62$9.05K7,550
Abraham Chesed
–
Oct 23, 2025Buy+14,286$4.60$65.72K1,447,268
Arthur F. Golden
Director
Oct 23, 2025Buy+20,202$4.95$100.00K30,202
Zuraiz Chaudhary
See Remarks
Oct 23, 2025Buy+5,050$4.95$25.00K5,050
Neilesh Shailesh Ghodadra
Chief Medical Officer, Director
Oct 8, 2025Award+10,000––10,000
Andrew Gengos
Director
Oct 8, 2025Award+10,000––10,000
Arthur F. Golden
Director
Oct 8, 2025Award+10,000––10,000
Kent Edward Kester
Director
Oct 8, 2025Award+10,000––10,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
3.89%
1M shares short
Days to cover
5.9
At 0M shares a day
Change since last report
+23.0%
From 0M shares
Short volume, 20 days
61.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Turn Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,577 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?